In terms of accessibility and compensation of new and effective medicine, Latvia is on the last place among EU member states, according to Patients W.A.I.T. Indicator published by European Federation of Pharmaceutical Industries and Associations at the end of April. According to the study, patients’ accessibility and state compensation for new medicine in Europe varies…
French companies expressed interest in investing in Armenia’s pharmaceutical and food industries, Minister of Economic Development and Investments Suren Karayan told journalists after a regular Cabinet session today. He said meetings were held with potential French investors during President Sargsyan’s visit to France earlier this month. “I would not like to go into the details,…
The Parliament in Poland has been considering new restrictions on the country’s pharmaceutical industry, placing strict limits on who can receive a license to operate a pharmacy, how many pharmacies can be operated by one proprietor, the allowable distance between planned pharmacies and ones already in operation, and other burdensome regulations. KoLiber Association, an Atlas…
We would like to extend a very big thank you to everyone who attended this year’s Global Pharmaceutical Regulatory Affairs Summit. In the heart of Berlin, industry experts gathered to discuss the latest global regulatory updates for regulatory affairs, eSubmissions and labelling.
The Baltics’ major medical exhibition Medbaltica brings together a variety of healthcare professionals, professional associations and manufacturers of medical products from Latvia and other countries. The exhibition marks the development of the healthcare industry as a whole, delivers current news and provides an opportunity to meet serious and reliable industry players. Read more
Ascendis Health Limited CEO Karsten Wellner South African over-the-counter (OTC) healthcare products maker Ascendis Health Limited said on Wednesday it plans to acquire Romanian alternative medicine products distributor Sun Wave Pharma for 42.5 million euro ($47.7 million). The business will be acquired with a maximum deferred payment of 23 million euro over three years based…
BMI View: Azerbaijan’s healthcare sector is at an inflection point as it attempts to reform the financing model away from a state-run system to a compulsory healthcare insurance model. Highlighting ongoing challenges for drugmakers operating in Azerbaijan, i n the short term, the country ‘s population will continue to be plagued with poor access ibility…
The European Medicines Agency (EMA) on Friday proposed a revision to its policy on accessing documents, extending the scope to include corporate documents, and increasing the publication of clinical data for pharmaceuticals. Since October 2016, EMA has published pharmaceutical trial data via its new website, including for: Mylan’s aripiprazole, published most recently on 31 January 2017,…
Sicor Biotech/Teva Baltic, the largest pharmaceutical company in Lithuania, is preparing to begin production of a new active medicinal ingredient to be used in the treatment of cancer. The ingredient, XM21, will be produced in the company’s Vilnius facility from this autumn. As Giedrius Žunda, the director of the Vilnius unit explains, XM21 is already…
An Iranian pharma company Monday broke ground on a plant it is building as a joint venture with Azerbaijan. Iran’s Darou Pakhsh Pharma Chem is building the $30 million plant in the Pirallahi Industrial Park, the Financial Tribune reports. The plant is projected to be commissioned in two years. Darou Pakhsh Pharma Chem last year…